PT71251A - Process for preparation of pyrimidin compounds - Google Patents
Process for preparation of pyrimidin compoundsInfo
- Publication number
- PT71251A PT71251A PT71251A PT7125180A PT71251A PT 71251 A PT71251 A PT 71251A PT 71251 A PT71251 A PT 71251A PT 7125180 A PT7125180 A PT 7125180A PT 71251 A PT71251 A PT 71251A
- Authority
- PT
- Portugal
- Prior art keywords
- preparation
- pyrimidin
- compounds
- pyrimidin compounds
- Prior art date
Links
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical class C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH466979 | 1979-05-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT71251A true PT71251A (en) | 1980-06-01 |
Family
ID=4280399
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT71251A PT71251A (en) | 1979-05-18 | 1980-05-16 | Process for preparation of pyrimidin compounds |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0019811A1 (pt) |
| JP (1) | JPS55154971A (pt) |
| KR (1) | KR830002757A (pt) |
| AR (1) | AR228256A1 (pt) |
| AU (1) | AU5848480A (pt) |
| DD (1) | DD150609A5 (pt) |
| DK (1) | DK214480A (pt) |
| ES (1) | ES491514A0 (pt) |
| FI (1) | FI801600A7 (pt) |
| GB (1) | GB2052487B (pt) |
| GR (1) | GR68453B (pt) |
| IE (1) | IE49803B1 (pt) |
| IL (1) | IL60086A (pt) |
| MA (1) | MA18829A1 (pt) |
| NO (1) | NO801469L (pt) |
| NZ (1) | NZ193730A (pt) |
| OA (1) | OA06533A (pt) |
| PL (1) | PL224313A1 (pt) |
| PT (1) | PT71251A (pt) |
| ZA (1) | ZA802909B (pt) |
| ZW (1) | ZW11880A1 (pt) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4507146A (en) * | 1982-12-28 | 1985-03-26 | Ciba-Geigy Corporation | 2,4-Diamino-6-halo-5-trifluoromethylpyrimidines having herbicidal activity |
| DE3829469A1 (de) * | 1988-08-31 | 1990-03-01 | Bayer Ag | Verfahren zur herstellung von substituierten n-azinyl-n'-sulfonyl-isothioharnstoffen und n-azinyl-iminodithiokohlensaeure-s,s-diester als zwischenprodukte zu ihrer herstellung |
| WO1999011269A1 (en) * | 1997-09-03 | 1999-03-11 | Eli Lilly And Company | Pyrimidine derivatives |
| WO2002022605A1 (en) | 2000-09-15 | 2002-03-21 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
| US6660731B2 (en) | 2000-09-15 | 2003-12-09 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
| US7473691B2 (en) | 2000-09-15 | 2009-01-06 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
| US6989385B2 (en) | 2000-12-21 | 2006-01-24 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
| CA2671776C (en) * | 2001-01-31 | 2012-12-18 | H. Lundbeck A/S | Gal3 receptor antagonists for the treatment of depression |
| MXPA04008901A (es) | 2002-03-13 | 2004-11-26 | Euro Celtique Sa | Pirimidinas arilo sustituidas y el uso de las mismas. |
| US20040009981A1 (en) | 2002-03-15 | 2004-01-15 | David Bebbington | Compositions useful as inhibitors of protein kinases |
| US7731985B2 (en) * | 2002-03-15 | 2010-06-08 | Ciba Specialty Chemicals Corporation | 4-aminopyrimidines and their use for the antimicrobial treatment of surfaces |
| MY141867A (en) | 2002-06-20 | 2010-07-16 | Vertex Pharma | Substituted pyrimidines useful as protein kinase inhibitors |
| CN1319968C (zh) | 2002-08-02 | 2007-06-06 | 沃泰克斯药物股份有限公司 | 用作gsk－3的抑制剂的吡唑组合物 |
| US7601718B2 (en) | 2003-02-06 | 2009-10-13 | Vertex Pharmaceuticals Incorporated | Compositions useful as inhibitors of protein kinases |
| ATE542814T1 (de) | 2005-08-18 | 2012-02-15 | Vertex Pharma | Pyrazinkinaseinhibitoren |
| MX2008005814A (es) | 2005-11-03 | 2008-10-15 | Vertex Pharma | Aminopirimidinas utiles como inhibidores de cinasa. |
| CA2668429A1 (en) | 2006-11-02 | 2008-05-15 | Vertex Pharmaceuticals Incorporated | Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases |
| ES2347721T3 (es) | 2006-12-19 | 2010-11-03 | Vertex Pharmaceuticals, Inc. | Aminopirimidinas utiles como inhibidores de proteina quinasas. |
| EP2137183B1 (en) | 2007-03-09 | 2011-09-28 | Vertex Pharmaceuticals Incorporated | Aminopyrimidines useful as inhibitors of protein kinases |
| EP2134709A1 (en) | 2007-03-09 | 2009-12-23 | Vertex Pharmaceuticals, Inc. | Aminopyridines useful as inhibitors of protein kinases |
| AU2008226457B2 (en) | 2007-03-09 | 2014-03-20 | Vertex Pharmaceuticals Incorporated | Aminopyrimidines useful as inhibitors of protein kinases |
| NZ580343A (en) | 2007-04-13 | 2012-03-30 | Vertex Pharma | Aminopyrimidines useful as kinase inhibitors |
| CA2694381A1 (en) | 2007-05-02 | 2008-11-13 | Vertex Pharmaceuticals Incorporated | Aminopyrimidines useful as kinase inhibitors |
| JP5389785B2 (ja) | 2007-05-02 | 2014-01-15 | バーテックス ファーマシューティカルズ インコーポレイテッド | キナーゼ阻害剤として有用なチアゾールおよびピラゾール |
| NZ582879A (en) | 2007-07-31 | 2012-03-30 | Vertex Pharma | Process for preparing 5-fluoro-1h-pyrazolo [3, 4-b] pyridin-3-amine and derivatives thereof |
| MX2011002312A (es) | 2008-09-03 | 2011-04-26 | Vertex Pharma | Co-cristales y formulaciones farmaceuticas que comprenden los mismos. |
| RS53347B (sr) * | 2008-12-09 | 2014-10-31 | Gilead Sciences, Inc. | Modulatori toll-sličnih receptora |
| KR102328682B1 (ko) * | 2018-08-27 | 2021-11-18 | 주식회사 대웅제약 | 신규한 헤테로사이클릭아민 유도체 및 이를 포함하는 약학 조성물 |
| WO2022101435A1 (en) * | 2020-11-12 | 2022-05-19 | 3Z Ehf | Novel treatments of attention deficit/hyperactivity disorder |
| CN121494792A (zh) * | 2026-01-14 | 2026-02-10 | 山东国邦药业有限公司 | 一种5-甲氧基-4,6-二羟基嘧啶的制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE754832A (fr) * | 1969-08-14 | 1971-02-15 | Beecham Group Ltd | Iminazolines |
-
1980
- 1980-05-05 MA MA19025A patent/MA18829A1/fr unknown
- 1980-05-13 DD DD80221082A patent/DD150609A5/de unknown
- 1980-05-14 ES ES491514A patent/ES491514A0/es active Granted
- 1980-05-15 NZ NZ193730A patent/NZ193730A/xx unknown
- 1980-05-15 IL IL60086A patent/IL60086A/xx unknown
- 1980-05-16 EP EP80102724A patent/EP0019811A1/de not_active Withdrawn
- 1980-05-16 AU AU58484/80A patent/AU5848480A/en not_active Abandoned
- 1980-05-16 ZW ZW118/80A patent/ZW11880A1/xx unknown
- 1980-05-16 DK DK214480A patent/DK214480A/da not_active Application Discontinuation
- 1980-05-16 PT PT71251A patent/PT71251A/pt unknown
- 1980-05-16 GR GR61963A patent/GR68453B/el unknown
- 1980-05-16 ZA ZA00802909A patent/ZA802909B/xx unknown
- 1980-05-16 GB GB8016309A patent/GB2052487B/en not_active Expired
- 1980-05-16 FI FI801600A patent/FI801600A7/fi not_active Application Discontinuation
- 1980-05-16 NO NO801469A patent/NO801469L/no unknown
- 1980-05-16 IE IE1023/80A patent/IE49803B1/en unknown
- 1980-05-17 PL PL22431380A patent/PL224313A1/xx unknown
- 1980-05-17 KR KR1019800001944A patent/KR830002757A/ko active Pending
- 1980-05-17 OA OA57113A patent/OA06533A/xx unknown
- 1980-05-17 JP JP6586380A patent/JPS55154971A/ja active Pending
- 1980-05-19 AR AR281109A patent/AR228256A1/es active
Also Published As
| Publication number | Publication date |
|---|---|
| FI801600A7 (fi) | 1981-01-01 |
| PL224313A1 (pt) | 1981-02-13 |
| OA06533A (fr) | 1981-07-31 |
| ZA802909B (en) | 1981-05-27 |
| ZW11880A1 (en) | 1980-12-17 |
| MA18829A1 (fr) | 1980-12-31 |
| EP0019811A1 (de) | 1980-12-10 |
| GB2052487A (en) | 1981-01-28 |
| DK214480A (da) | 1980-11-19 |
| DD150609A5 (de) | 1981-09-09 |
| AR228256A1 (es) | 1983-02-15 |
| KR830002757A (ko) | 1983-05-30 |
| IL60086A0 (en) | 1980-07-31 |
| NZ193730A (en) | 1982-12-21 |
| IL60086A (en) | 1984-03-30 |
| ES8104279A1 (es) | 1981-04-16 |
| IE49803B1 (en) | 1985-12-25 |
| NO801469L (no) | 1980-11-19 |
| JPS55154971A (en) | 1980-12-02 |
| GB2052487B (en) | 1983-05-11 |
| IE801023L (en) | 1980-11-18 |
| ES491514A0 (es) | 1981-04-16 |
| GR68453B (pt) | 1981-12-30 |
| AU5848480A (en) | 1980-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT71251A (en) | Process for preparation of pyrimidin compounds | |
| DE3060027D1 (en) | Process for the preparation of benzimidazolylbenzofurans | |
| DE3062020D1 (en) | Process for the preparation of neopentylamine | |
| DE3060131D1 (en) | Process for the direct preparation of beta-methylthio-propionaldehyde | |
| DE3060155D1 (en) | Process for the preparation of thiazolidine-2-thiones | |
| DE3060854D1 (en) | Process for the preparation of 3-phenoxybenzaldehydes | |
| DE3063952D1 (en) | Process for the preparation of riboflavin | |
| PT70882A (en) | Preparation process of new pyrimidine derivatives | |
| DE3064993D1 (en) | Process for the preparation of hexahydronaphthacene derivatives | |
| PT71582A (en) | Process for the preparation of 3-methyleneazetidine derivatives | |
| GB2042542B (en) | Process for the preparation of meta-chloroanilines | |
| DE3065967D1 (en) | Process for the preparation of diorganomagnesium compounds | |
| PT71031A (en) | Process for the preparation of benzodiazepine derivatives | |
| GB2022606B (en) | Process for the preparation of thiondigo compounds | |
| PT70716A (en) | Process for the preparation of novel spiro-quinolylhydantoin derivatives | |
| DE3062386D1 (en) | Process for the preparation of 3-hydroxycepham compounds | |
| GB2098208B (en) | Process for the preparation of 7-acylindolines | |
| MW880A1 (en) | Process for preparation of b-lactam compounds | |
| IL58287A (en) | Process for the preparation of 3-carbamoyloxymethyl cephalosporin compounds | |
| PT72029B (en) | Process for the preparation of cationic compounds of the naphthalimid series | |
| GB2051053B (en) | Process for the preparation of d-a-aminoacids | |
| YU122180A (en) | Process for obtaining derivatives of condensed pyrimidin-4-one compounds | |
| DE3061336D1 (en) | Process for the preparation of dihalovinyl compounds | |
| DE2964328D1 (en) | Process for the preparation of m-amino-phenols | |
| DE3067208D1 (en) | Process for the preparation of coumarin compounds |